Study summary

Watching instead of operating did not shorten survival at 2 years

SANO · 309 people, the Netherlands · Published 2025, Lancet Oncology

74% vs 71%alive at 2 years, watching vs surgery

What was tested

After chemoradiation, people with no sign of remaining cancer either had surgery as usual or were watched closely, with surgery only if the cancer came back. Both types of esophageal cancer were included.

What they found

What it means

The best evidence so far that some people can avoid an esophagectomy. The larger NEEDS trial tests this in squamous cancer specifically.

Lancet Oncology, via PubMed ↗ ← Back to the outlook
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.